The number of people with susceptibility test result for rifampicin in Pakistan
Pakistan: The number of people with susceptibility test result for rifampicin was 91.93 in 2021. ▲ Rising
Latest (2021)
91.93
Change on year
up 30.3%
World rank
63rd
of 146 countries
All-time high
91.93
in 2021
All-time low
28.05
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Pakistan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Pakistan recorded 91.93 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
The figure is up 30.3% on the previous year and up 227.7% over five years.
Pakistan ranks 63rd of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Pakistan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 28.05 | — |
| 2018 | 45.15 | +60.9% |
| 2019 | 58.72 | +30.1% |
| 2020 | 70.57 | +20.2% |
| 2021 | 91.93 | +30.3% |
Pakistan compared with similar countries
- Pakistan's 91.93 is above the median for lower middle income countries, which is 78.77, 1.2× the median. (32 countries reporting)
- Pakistan's 91.93 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 1.0× the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 43.98 | 28.05 | 58.72 | 3 |
| 2020s | 81.25 | 70.57 | 91.93 | 2 |
Countries ranked near Pakistan
More health data for Pakistan
- Un projection of annual infant deaths, annual growth rate -2.14 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8219 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 944.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 55,286 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 335 (2025)
- Population ages 00-04, female, annual growth rate 0.5028 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0616 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Pakistan?
- The number of people with susceptibility test result for rifampicin in Pakistan was 91.93 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Pakistan?
- The highest recorded value was 91.93 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Pakistan?
- The lowest recorded value was 28.05 in 2017.
- How does Pakistan rank for the number of people with susceptibility test result for rifampicin?
- Pakistan ranks 63rd out of 146 countries with data for 2021.
- Where does this Pakistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).